Stimulants

Expert Q&A

Unpacking Aggression Associated with ADHD

Topics: ADHD | aggression | Risperidone | Stimulants | Valproate

CCPR: You recently did a study on stepped treatment for ADHD and aggressive behavior (Blader JC et al, J Am Acad Child Adolesc Psychiatry 2021;60(2):236–251). It is riveting in its relevance to everyday practice. I am thinking of one school-age child who came to me after multiple trials of stimulants and mood stabilizers who was still very impulsively

Read More
Research Update

Which Medications Have the Lowest Risk of Side Effects?

Topics: Antidepressants | Antipsychotics | Lithium | Mood Stabilizers | Psychotropic medication | Side Effects | Stimulants

REVIEW OF: Solmi M et al, World Psychiatry 2020;19(2):214–232 Adverse effects are important considerations when choosing psychotropic medications, especially in children and adolescents. This study pooled available research to compare the safety profiles of various psychotropics used in the pediatric population. The authors screened thousands of st

Read More
Clinical Update

Pharmacotherapy for Stimulant Use Disorders

Topics: medications | Pharmacotherapy | Stimulants

Stimulant use is surprisingly common. In 2017, 5.5 million people in the US took cocaine, and 757,000 of these people used crack. Another 5.1 million people misused prescription stimulants, representing nearly 2% of the total population (SAMHSA, 2019; www.samhsa.gov/data/). Many pharmacological trials for stimulant use disorder have been conducted, but

Read More
Expert Q&A

Diagnosing and Treating Stimulant Use Disorders

Topics: contingency management | Diagnosis | Harm reduction | online therapy | Pharmacotherapy | Psychotherapy | Stimulants

CATR: Welcome, Dr. dela Cruz. Tell us what you do. Dr. dela Cruz: I’m an assistant professor at UT Southwestern Medical School where I’m the adult psychiatry residency associate program director, and I teach medical students, residents, and fellows. Clinically, I’m an outpatient addiction psychiatrist where I treat a variety of patients with subs

Read More
In Brief

The Other Pandemic

Topics: Opioids | Stimulants

Predictions that overdose mortality would worsen during the COVID-19 pandemic have unfortunately proven accurate. Recent data outlined in an alert by the CDC show that rates of overdose deaths from opioids and stimulants accelerated at an alarming rate between March and May 2020, the period coinciding with widespread lockdowns (www.tinyurl.com/4ductzzx)

Read More
Clinical Update

Atomoxetine: Myths and Truths

Topics: ADHD | Atomoxetine | stimulant | Stimulants

Atomoxetine (Strattera) is approved for ADHD in children and adults but has also been explored in many other disorders. That has led to some myths and truths that we’ll explore here. First, a little about atomoxetine’s mechanism of action. Atomoxetine is a selective norepinephrine reuptake inhibitor, a mechanism shared by maprotiline, a long-forg

Read More
Clinical Update

Stimulants and Creativity

Topics: ADHD | Amphetamines | ArModafinil | Attention Deficit Hyperactivity Disorder | Creativity | methylphenidate | Modafinil | Provigil | Side Effects | stimulant | Stimulants

Your patient is a 25-year-old music teacher with ADHD. Though her organizational skills have improved with methylphenidate, she complains that it impairs her performance as a jazz musician: “I feel self-conscious, like a robot.” Popular lore holds that creative people have ADHD traits and that ADHD bestows advantages in creative thinking. Stock cha

Read More